GOLD 2021 Strategy Report: Implications for Asthma–COPD Overlap

References

• Gee S. The Lumleian lectures on bronchitis, pulmonary emphysema, and asthma: delivered before the Royal College of Physicians of London. Br Med J. 1899;1(1994):645–649. doi:10.1136/bmj.1.1994.645
   PubMedGoogle Scholar
• Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8):728–735. doi:10.1136/thx.2008.108027
   PubMed Web of Science ®Google Scholar
• Miravitlles M. Asthma-COPD overlap (ACO) PRO-CON debate. ACO: call me by my name. COPD. 2020;17(5):471–473. doi:10.1080/15412555.2020.1817883
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2021 report) 2020; 2020. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed February 2, 2021.
   Google Scholar
• Global Initiative for Asthma, Global Initiative for Chronic Obstructive Lung Disease. Diagnosis of diseases of chronic airflow limitation: asthma COPD and asthma - COPD overlap syndrome (ACOS); 2015. Available from: https://goldcopd.org/wp-content/uploads/2016/04/GOLD_ACOS_2015.pdf. Accessed December 4, 2020.
   Google Scholar
• Soler-Cataluna JJ, Cosio B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48(9):331–337. doi:10.1016/j.arbr.2012.06.017
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Alvarez-Gutierrez FJ, Calle M, et al. Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines. Eur Respir J. 2017;49(5):1700068. doi:10.1183/13993003.00068-2017
   PubMed Web of Science ®Google Scholar
• Koblizek V, Chlumsky J, Zindr V, et al. Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Papers Med Faculty Palacky Univ Olomouc. 2013;157(2).
   Google Scholar
• Miravitlles M, Calle M, Molina J, et al. Spanish COPD guidelines (GesEPOC) 2021: updated pharmacological treatment of stable COPD. Arch Bronconeumol. 2021. doi:10.1016/j.arbr.2021.03.014
   Web of Science ®Google Scholar
• Bourbeau J, Bhutani M, Hernandez P, et al. CTS position statement: pharmacotherapy in patients with COPD—an update. Can J Respir Crit Care Sleep Med. 2017;1(4):222–241. doi:10.1080/24745332.2017.1395588
   Web of Science ®Google Scholar
• Bourbeau J, Bhutani M, Hernandez P, et al. Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Can J Respir Crit Care Sleep Med. 2019;3(4):210–232. doi:10.1080/24745332.2019.1668652
   Web of Science ®Google Scholar
• Sin DD, Miravitlles M, Mannino DM, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48(3):664–673. doi:10.1183/13993003.00436-2016
   PubMed Web of Science ®Google Scholar
• Rogliani P, Ora J, Puxeddu E, et al. Airflow obstruction: is it asthma or is it COPD? Int J Chron Obstruct Pulmon Dis. 2016;11:3007–3013. doi:10.2147/COPD.S54927
   PubMed Web of Science ®Google Scholar
• Moore C. Implementing an asthma and COPD overlap protocol in general practice. Nurs Times. 2020;116(4):31–34.
   Google Scholar
• Cosentino J, Zhao H, Hardin M, et al. Analysis of asthma-chronic obstructive pulmonary disease overlap syndrome defined on the basis of bronchodilator response and degree of emphysema. Ann Am Thorac Soc. 2016;13(9):1483–1489. doi:10.1513/AnnalsATS.201511-761OC
   PubMed Web of Science ®Google Scholar
• Menezes AMB, Montes de Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145(2):297–304. doi:10.1378/chest.13-0622
   PubMed Web of Science ®Google Scholar
• Che-Morales JL, Valle-Pina J, Carrillo-Chan J. [Asthma-chronic obstructive pulmonary disease overlap syndrome: clinical-functional profile]. Rev Med Inst Mex Seguro Soc. 2019;57(5):284–290. Swedish.
   PubMedGoogle Scholar
• Nissen F, Morales DR, Mullerova H, et al. Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care. Br J Gen Pract. 2018;68(676):e775–e82. doi:10.3399/bjgp18X699389
   PubMed Web of Science ®Google Scholar
• Barrecheguren M, Roman-Rodriguez M, Miravitlles M. Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD? Int J Chron Obstruct Pulmon Dis. 2015;10:1745–1752. doi:10.2147/COPD.S87025
   PubMed Web of Science ®Google Scholar
• Baron AJ, Flokstra-de Blok BMJ, van Heijst E, et al. Prevalence of asthma characteristics in COPD patients in a Dutch well-established asthma/COPD service for primary care. Int J Chron Obstruct Pulmon Dis. 2020;15:1601–1611. doi:10.2147/COPD.S247819
   PubMed Web of Science ®Google Scholar
• Koblizek V, Milenkovic B, Barczyk A, et al. Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study. Eur Respir J. 2017;49(5):pii:1601446. doi:10.1183/13993003.01446-2016
   Web of Science ®Google Scholar
• Barczyk A, Maskey-Warzechowska M, Gorska K, et al. Asthma-COPD overlap-a discordance between patient populations defined by different diagnostic criteria. J Allergy Clin Immunol Pract. 2019;7(7):2326–36e5. doi:10.1016/j.jaip.2019.04.022
   PubMed Web of Science ®Google Scholar
• Jameson JL, Longo DL. Precision medicine–personalized, problematic, and promising. N Engl J Med. 2015;372(23):2229–2234. doi:10.1056/NEJMsb1503104
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Andreu I, Romero Y, et al. Difficulties in differential diagnosis of COPD and asthma in primary care. Br J Gen Pract. 2012;62(595):e68–75. doi:10.3399/bjgp12X625111
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention (2020 report); 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf. Accessed May 13, 2020.
   Google Scholar
• Cataldo D, Derom E, Liistro G, et al. Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice. Int J Chron Obstruct Pulmon Dis. 2018;13:2089–2099. doi:10.2147/COPD.S164259
   PubMed Web of Science ®Google Scholar
• McDonald VM, Fingleton J, Agusti A, et al. Treatable traits: a new paradigm for 21st century management of chronic airway diseases: treatable traits down under international workshop report. Eur Respir J. 2019;53(5):1802058. doi:10.1183/13993003.02058-2018
   PubMed Web of Science ®Google Scholar
• Janson C, Malinovschi A, Amaral AFS, et al. Bronchodilator reversibility in asthma and COPD: findings from three large population studies. Eur Respir J. 2019;54(3):1900561. doi:10.1183/13993003.00561-2019
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Strange C. Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy? Int J Chron Obstruct Pulmon Dis. 2018;13:2587–2601. doi:10.2147/COPD.S172240
   PubMed Web of Science ®Google Scholar
• Toledo-Pons N, van Boven JFM, Roman-Rodriguez M, et al. ACO: time to move from the description of different phenotypes to the treatable traits. PLoS One. 2019;14(1):e0210915. doi:10.1371/journal.pone.0210915
   PubMed Web of Science ®Google Scholar
• Christenson SA, Steiling K, van den Berge M, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):758–766. doi:10.1164/rccm.201408-1458OC
   PubMed Web of Science ®Google Scholar
• de Abreu FC, da Silva Júnior JLR, Rabahi MF. The fraction exhaled nitric oxide as a biomarker of asthma control. Biomark Insights. 2019;14:1177271919826550. doi:10.1177/1177271919826550
   Web of Science ®Google Scholar
• Kuruvilla ME, Lee FE-H, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56(2):219–233. doi:10.1007/s12016-018-8712-1
   PubMed Web of Science ®Google Scholar
• Singh S, Loke YK. Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update. Curr Opin Pulm Med. 2010;16(2):118–122. doi:10.1097/MCP.0b013e328334c085
   PubMed Web of Science ®Google Scholar
• Leung JM, Sin DD. Inhaled corticosteroids in COPD: the final verdict is. Eur Respir J. 2018;52(6):1801940. doi:10.1183/13993003.01940-2018
   PubMed Web of Science ®Google Scholar
• Brassard P, Suissa S, Kezouh A, et al. Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med. 2011;183(5):675–678. doi:10.1164/rccm.201007-1099OC
   PubMed Web of Science ®Google Scholar
• Buehring B, Viswanathan R, Binkley N, et al. Glucocorticoid-induced osteoporosis: an update on effects and management. J Allergy Clin Immunol. 2013;132(5):1019–1030. doi:10.1016/j.jaci.2013.08.040
   PubMed Web of Science ®Google Scholar
• Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med. 2003;114(1):10–14. doi:10.1016/s0002-9343(02)01297-4
   PubMed Web of Science ®Google Scholar
• Price DB, Russell R, Mares R, et al. Metabolic effects associated with ICS in patients with COPD and comorbid type 2 diabetes: a historical matched cohort study. PLoS One. 2016;11(9):e0162903. doi:10.1371/journal.pone.0162903
   PubMed Web of Science ®Google Scholar
• Suissa S, Kezouh A, Ernst P. Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med. 2010;123(11):1001–1006. doi:10.1016/j.amjmed.2010.06.019
   PubMed Web of Science ®Google Scholar
• Shroff S, Thomas RK, D’Souza G, et al. The effect of inhaled steroids on the intraocular pressure. Digit J Ophthalmol. 2018;24(3):6–9. doi:10.5693/djo.01.2018.04.001
   PubMedGoogle Scholar
• Weatherall M, Clay J, James K, et al. Dose-response relationship of inhaled corticosteroids and cataracts: a systematic review and meta-analysis. Respirology. 2009;14(7):983–990. doi:10.1111/j.1440-1843.2009.01589.x
   PubMed Web of Science ®Google Scholar
• Singanayagam A, Glanville N, Cuthbertson L, et al. Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease. Sci Transl Med. 2019;11(507):eaav3879. doi:10.1126/scitranslmed.aav3879
   PubMed Web of Science ®Google Scholar
• Brode SK, Campitelli MA, Kwong JC, et al. The risk of mycobacterial infections associated with inhaled corticosteroid use. Eur Respir J. 2017;50(3):1700037. doi:10.1183/13993003.00037-2017
   PubMed Web of Science ®Google Scholar
• Cukic V, Lovre V, Dragisic D, et al. Asthma and chronic obstructive pulmonary disease (COPD) - differences and similarities. Mater Sociomed. 2012;24(2):100–105. doi:10.5455/msm.2012.24.100-105
   PubMedGoogle Scholar
• Agusti A, Fabbri LM, Singh D, et al. Inhaled corticosteroids in COPD: friend or foe? Eur Respir J. 2018;52(6):1801219. doi:10.1183/13993003.01219-2018
   PubMed Web of Science ®Google Scholar
• Oshagbemi OA, Burden AM, Braeken DCW, et al. Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts. Am J Respir Crit Care Med. 2017;195(10):1402–1404. doi:10.1164/rccm.201701-0009LE
   PubMed Web of Science ®Google Scholar
• Novartis Pharmaceuticals UK Ltd. Enerzair breezhaler; 2020. Available from: https://www.medicines.org.uk/emc/product/11886/smpc#gref. Accessed January 20, 2021.
   Google Scholar
• GlaxoSmithKline. FDA approves Trelegy Ellipta as the first once-daily single inhaler triple therapy for the treatment of both asthma and COPD in the US 2020; 2020. Available from: https://www.gsk.com/en-gb/media/press-releases/fda-approves-trelegy-ellipta-as-the-first-once-daily-single-inhaler-triple-therapy-for-the-treatment-of-both-asthma-and-copd-in-the-us/. Accessed January 20, 2021.
   Google Scholar